期刊文献+

鼻咽癌64排CT表现与bcl-2蛋白表达关系的研究 被引量:2

Study of 64-CT with bcl-2 Protein Expression in Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的研究bcl-2蛋白表达与鼻咽癌64排CT表现的关系。方法经活检病理证实的鼻咽癌30例,均行64排螺旋CT扫描,收集CT征象,采用免疫组织化学方法检测bcl-2蛋白表达情况,并分析CT征象与其bcl-2蛋白表达的相应关系。结果 bcl-2蛋白阳性表达率在鼻咽癌单侧壁肿块组与多侧壁肿块组分别为72.22%与83.33%,差异无显著性意义(P>0.05);在咽旁脂肪间隙消失组与无咽旁脂肪间隙消失组分别为100%与11.11%,差异有显著性意义(P<0.05);侵及后鼻道组与无侵及后鼻道组分别为93.75%与64.27%,差异有显著性意义(P<0.05);侵及上颌窦组与无侵及上颌窦组分别为89.47%与54.54%,差异有显著性意义(P<0.05)。在颅底骨质破坏组与无颅底骨质破坏组,bcl-2蛋白阳性表达率分别为100%与37.5%,差异有显著性意义,(P<0.05),颈部淋巴结转移组与无颈部淋巴结转移组分别为80%与75%,差异无显著性意义(P>0.05)。结论 bcl-2蛋白在鼻咽癌的发生、发展中起重要作用,其阳性表达与鼻咽癌的浸润深度有一定的相关性,因此bcl-2蛋白表达率可作为评价鼻咽癌CT表现恶性程度的指标。 Objective To study the relationship between the expression of bcl-2 and 64-CT findings of nasopharyngeal carcinoma(NPC).Methods 30 patients of NPC were confirmed by biopsy with 64-CT scanning,then the relationship between the expressions ofbcl-2 and CT features was analyzed.Results The positive expression rates of bcl-2 were 72.22% and 83.33% in the single lateral wall and the multiple lateral wall of nasopharynx(P0.05) respectively.The positive expression rates of bcl-2 were 100.00% and 11.11% in para pharyngeal space narrowing respectively(P0.05).It were 93.75% and 64.27% in posterior naris involved and without(P0.05).It were 89.47% and 54.54% in lower pharyngeal involved and without(P0.05).It were 100.00% and 37.50% in bone destruction of skull base and without(P0.05).It were 80.00% and 78.57% in lymph node metastasis in neck and without(P0.05).Conclusion Bcl-2 might play an important role in development of nasopharyngeal carcinoma.Bcl-2 protein expression was correlated with invasive depth and prognosis metastasis.Bcl-2 could be served as indicator for predicting prognosis and malignancy of CT findings of nasopharyngeal carcinoma.
出处 《中国医疗设备》 2011年第2期142-144,共3页 China Medical Devices
关键词 鼻咽癌 BCL-2蛋白 免疫组化 CT征象 医学影像 nasopharyngeal carcinoma bcl-2 immunohisto chemistry CT features medical imaging
  • 相关文献

参考文献4

二级参考文献66

  • 1郝春明,赫荣乔.蛋白质的选择性降解机制——2004年诺贝尔化学奖部分工作介绍[J].生物化学与生物物理进展,2004,31(11):975-978. 被引量:4
  • 2周艳宏,曾朝阳,熊炜,罗晓敏,李小玲,范松青,张文玲,刘华英,李征,杨一新,武明花,唐珂,曹利,沈守荣,李桂源.鼻咽癌组织的显微切割及其RNA线性扩增[J].生物化学与生物物理进展,2005,32(5):463-467. 被引量:8
  • 3[1]Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma:relationship to diatant metastasis and survival [J].J Clin Oncol, 2001,19(10):2607-2615.
  • 4[2]Hsiao JR, Jin YT, Tsai ST. Detection of cell free Epstein-Barr virus DNA in sera from patient with nasopharyngeal carcinoma [J].Cancer,2002,94(3):723-729.
  • 5[3]Lo YM, Chan AT, Chan LY, et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulation Epstein-Barr virus DNA [J].Cancer Res, 2000,60(24):6878-6881.
  • 6[4]Ngan RK, Lau WH, Yip TT, et al. Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy [J]. Ann N Y Acad Sci,2001,945(1):73-79.
  • 7[5]Yoshizaki T, Miwa H, Takeshita H, et al. Elavation of antibody against Epstein-Barr virus genes BRLF1 and BZLF1 in nasopharyngeal carcinoma [J]. J Cancer Res Clin Oncol, 2000,126(2):69-73.
  • 8[6]Dardari R, Khyatti M, Benider A, et al. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma [J]. Iht J Cancer, 2000,86(1):71-75.
  • 9[7]Yoshizaki T,Miyamori H,Hasegawa K,et al.Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth [J]. Oncogene,2000,19(14):1764-1771.
  • 10[8]Fukuda M, Ikuta K, Yanagihara K, Tajima M, Kuratsune H, et al. Effect of transforming growth factor-betal on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines [J]. Virology,2001,288(1):109-118.

共引文献18

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部